Vectors Research Management LLC Reduces Position in UnitedHealth Group Incorporated (NYSE:UNH)

Vectors Research Management LLC lessened its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.0% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,907 shares of the healthcare conglomerate’s stock after selling 29 shares during the quarter. Vectors Research Management LLC’s holdings in UnitedHealth Group were worth $1,708,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Kathleen S. Wright Associates Inc. acquired a new position in shares of UnitedHealth Group in the 3rd quarter valued at $27,000. Macroview Investment Management LLC grew its stake in shares of UnitedHealth Group by 671.4% in the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after buying an additional 47 shares in the last quarter. Bbjs Financial Advisors LLC acquired a new stake in UnitedHealth Group during the 2nd quarter worth $31,000. Global Wealth Strategies & Associates boosted its holdings in UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after purchasing an additional 32 shares in the last quarter. Finally, Signature Resources Capital Management LLC grew its stake in shares of UnitedHealth Group by 40.0% during the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after purchasing an additional 18 shares during the period. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $593.30 on Friday. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The business’s fifty day simple moving average is $582.99 and its 200-day simple moving average is $548.03. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The company has a market cap of $546.00 billion, a PE ratio of 38.65, a PEG ratio of 1.78 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. During the same period in the prior year, the firm earned $6.56 earnings per share. The business’s revenue for the quarter was up 9.2% compared to the same quarter last year. Analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be issued a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.42%. UnitedHealth Group’s payout ratio is currently 54.72%.

Analyst Upgrades and Downgrades

UNH has been the subject of a number of research analyst reports. HSBC downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 17th. UBS Group decreased their price target on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. KeyCorp started coverage on shares of UnitedHealth Group in a research note on Friday, October 11th. They issued an “overweight” rating and a $675.00 price target on the stock. Hsbc Global Res downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Thursday, October 17th. Finally, StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Tuesday. Three research analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $615.53.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.